An update from Acrux Limited ( (AU:ACR) ) is now available.
Acrux Limited has announced the quotation of 3,714,284 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of February 13, 2025. This development marks a strategic move for Acrux, potentially enhancing its market presence and liquidity, and offering stakeholders new opportunities for growth within the pharmaceutical sector.
More about Acrux Limited
Acrux Limited operates in the pharmaceutical industry, focusing on the development and commercialization of specialty topical products. The company targets various global markets with its innovative drug delivery solutions.
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.86M
Find detailed analytics on ACR stock on TipRanks’ Stock Analysis page.